Assessment of Adherence, Quality of Life, and Self-efficacy Among Iraqi Patients with Systemic Lupus Erythematosus: A Single-center Study

Authors

  • Basma Zuheir Al-Metwali Department Clinical Pharmacy , College of Pharmacy, University of Baghdad, Baghdad, Iraq.
  • Roaa Tahseen Al-Mandalawi Ministry of Health, Al-Rashad Stores for Medicines, Al-Rusafa Baghdad Health Directorate, Baghdad, Iraq.
  • Faiq Isho Gorial Department of Medicine, Rheumatology Unit, College of Medicine, University of Baghdad, Baghdad, Iraq.

DOI:

https://doi.org/10.31351/vol35iss2pp90-104

Keywords:

SLE, Iraqi patients, adherence, quality of life, self-efficacy, flu vaccine

Abstract

Systemic Lupus Erythematosus (SLE) is an immune-mediated disease with severe morbidity and tissue damage. Adherence to therapy in SLE patients remains a significant problem, and nonadherence can lead to poor disease outcomes and decreased quality of life. Self-efficacy is also a critical aspect of disease control and medication adherence. This study aims to evaluate medication adherence, quality of life, and self-efficacy among patients with SLE and their correlation with sociodemographic and clinical factors. This was cross-sectional study was conducted at Baghdad Teaching Hospital's Rheumatology Unit from November 2024 to January 2025, evaluating adherence, quality of life, and self-efficacy among SLE patients using the Compliance Questionnaire for Rheumatology (CQR), the World Health Organisation Quality of Life Questionnaire (WHOQOL-BREF), and Self-Efficacy for Managing Chronic Disease 6-Item Scale (SEMCD) respectively. In addition, the SLEDAI was used to measure the disease activity. The study recruited 118 individuals aged 35.03±10.52 years old on average, and 94.1% did not receive the flu vaccine in the past year. The average CQR score was 64.32, and 12.7% of the patients adhered to the therapy; the WHOQOL-BREF psychological score was at its minimum value of 9.90, while the social score attained the maximum value of 12.21, and the average SEMCD score for the subjects was 39.88. The adherence score significantly correlated with residency and SELENA-SLEDAI. In addition, WHOQOL-BREF scores demonstrated a significant correlation with residency, exercise, SELENA-SLEDAI, disease duration, and the number of chronic diseases. The SES6C score is also associated with residency, SELENA-SLEDAI, and the number of chronic drugs. The study identified a significant positive correlation among self-efficacy scores, medication adherence scores, and four aspects of quality of life. The study concluded that patients with SLE demonstrated low flu vaccine uptake, suboptimal medication adherence, relatively low quality of life regarding the psychological domain score, and relatively high self-efficacy in managing chronic disease. Finally, the study revealed the need for effective communication between healthcare providers and patients regarding infection risks and benefits of flu vaccine. Furthermore, augmenting patient education to enhance medication adherence and improve self-efficacy in managing chronic disease can positively impact treatment outcomes and, hence, patient quality of life.

How to Cite

1.
Basma Zuheir Al-Metwali, Roaa Tahseen Al-Mandalawi, Faiq Isho Gorial. Assessment of Adherence, Quality of Life, and Self-efficacy Among Iraqi Patients with Systemic Lupus Erythematosus: A Single-center Study. Iraqi Journal of Pharmaceutical Sciences [Internet]. 2026 Jun. 24 [cited 2026 Jun. 25];35(2):90-104. Available from: https://www.bijps.uobaghdad.edu.iq/index.php/bijps/article/view/4557

Publication Dates

Received

2025-04-10

Revised

2025-06-04

Accepted

2025-10-22

Published Online First

2026-06-24

References

Siegel CH, Sammaritano LR. Systemic lupus erythematosus: a review. Jama Journal. 2024;331(17):1480-91.

AL-Qubaeissy KY, Abdulsamad T, Al-Rawi Z, et al. Does Rheumatoid Factor have any Protective Role in Patients with Lupus Nephritis. Al-Anbar Medical Journal. 2020;16(2):40-5.

Jiang M, Near AM, Desta B, et al. Disease and economic burden increase with systemic lupus erythematosus severity 1 year before and after diagnosis: a real-world cohort study, United States, 2004–2015. Lupus science & medicine. 2021;8(1): e000503.

De Geest S, Sabaté E. Adherence to long-term therapies: evidence for action. European Journal of Cardiovascular Nursing. 2003;2(4):323-.

Georgopoulou S, Nel L, Sangle SR, et al. Physician–patient interaction and medication adherence in lupus nephritis. Lupus. 2020;29(10):1168-78.

Albuquerque ES, Pinto LD, Neto VL, et al. Medication adherence in systemic lupus erythematosus during Brazilian COVID-19 pandemic. Lupus. 2022;31(2):221-7.

Kelly A, Crimston-Smith L, Tong A, et al. Scope of outcomes in trials and observational studies of interventions targeting medication adherence in rheumatic conditions: a systematic review. The Journal of Rheumatology. 2020;47(10):1565-74.

Group WHO. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychological medicine. 1998;28(3):551-8.

Souza RRd, Marcon SS, Teston EF, et al. Factors influencing quality of life in people with systemic lupus erythematosus. Acta Paulista de Enfermagem. 2021;34:1-10.

Saletra A, Olesińska M. Quality of life in systemic lupus erythematosus and its measurement. Reumatologia. 2018;56(1):45-54.

Uchmanowicz B, Chudiak A, Mazur G. The influence of quality of life on the level of adherence to therapeutic recommendations among elderly hypertensive patients. Patient preference and adherence. 2018;12:2593-603.

Bandura A, Freeman W, Lightsey R. Self-Efficacy: The exercise of control. Journal of Cognitive Psychotherapy. 1999;13(2):158-66.

Brady TJ, Murphy L, O’Colmain BJ, et al. A meta-analysis of health status, health behaviors, and health care utilization outcomes of the chronic disease self-management program. Preventing chronic disease. 2013;10:E07.

Huang Y-M, Shiyanbola OO, Smith PD. Association of health literacy and medication self-efficacy with medication adherence and diabetes control. Patient preference and adherence. 2018;12:793-802.

Ugarte-Gil MF, Gamboa-Cardenas RV, Reátegui-Sokolova C, et al. A better self-efficacy is predictive of better health-related quality of life (HRQoL) in patients with systemic lupus erythematosus: data from the Almenara Lupus Cohort. Lupus science & medicine. 2023;10(1):1-7.

Ziad S. Al - Rawi NAM, Humam Abdulrahman Ibrahim. Factors Influencing Medication Adherence Among

Female Patients with Systemic Lupus Erythematosus in Iraq. International Journal of Science and Research. 2024;13(12):1014–21.

Omar S Fadhil, Faiq Isho Gorial. Medications Adherence among a Sample of Patients with Ankylosing Spondylitis. Iraqi Postgraduate Medical Journal. 2023;22(1):33-40.

Al-Tuma A, Jassim N. Adherence to methotrexate in Iraqi patients with rheumatoid arthritis: a cross-sectional study. Global Journal of Public Health Medicine. 2022;4(1):618-30.

Mikhael E, Al-Rubaye M. Assessing the adherence to insulin therapy and the effect of injection pain on insulin adherence among type 2 diabetes mellitus patients. Journal of Pharmaceutical Negative Results. 2020;11(1):65.

Showaya A, Jawad K. Correlation between adherence to medication and social support on patients with diabetes mellitus. Pakistan Heart Journal. 2023;56(2):696-8.

Jammal MY. Factors associated with adherence to insulin self-administration among children and adolescents with type 1 DM in Iraq. Iraqi Journal of Pharmaceutical Sciences. 2023;32(3):291-9.

Mohammed RS, Al-Jobori SS, Altemimi ZH. Quality of Life among Patients with Systemic Lupus Erythematosus and its Association with Sociodemographic and Clinical Parameters in Karbala Governorate. Karbala Journal of Medicine. 2024;17(2):2746-54.

Al-Metwali BZ, AL-Ameen TM. Comparison of Quality of Life and Treatment Satisfaction among Sample of Iraqi Patients Using Anticoagulant Therapy (Warfarin or Non-Vitamin K Antagonist Oral Anticoagulants). Journal of the Faculty of Medicine Baghdad. 2024;66(3):268-75.

Najaf HN, Kadhim DJ. Health-Related Quality of Life among a Sample of Chronic Hepatitis B Patients in AL-Najaf Province/Iraq. Iraqi Journal of Pharmaceutical Sciences. 2020;29(1):33-40.

Sabry SA, Ibrahem MJ, Jabarah MA. Relationship of the quality of life in capecitabine-treated colorectal cancer patients to sociodemographic characteristics and drug-related adverse effects. Journal of the Faculty of Medicine Baghdad. 2022;64(3):175-82.

Ghayadh A, Naji A. Treatment adherence and its association to quality of life among patients with hypertension. Pakistan Heart Journal. 2023;56(2):44-9.

Qasim TH, Ibraheem MJ, Jabarah MA-H. Impact of sociodemographic characteristics and drug-related side effects on quality of life of patients with hepatocellular carcinoma receiving sorafenib treatment in Iraqi hospitals. Journal of the Faculty of Medicine Baghdad. 2022;64(4):286-91.

Hamza SH, Faraj RK. Self-efficacy for Clients with Diabetes Mellitus Type II Who Attend to Diabetic Center in Al-Diwaniyah City. Indian Journal of Forensic Medicine & Toxicology. 2021;15(3):5372-9.

Madran DM, Jassim AH. Self-efficacy and its relationship to self-care among type II diabetic patients. International journal of health sciences. 2022;6(S2):15199-208.

Al-Ameen TM, Al-Metwali BZ. Assessment of Adherence and Self-Efficacy in a Sample of Iraqi Patients Receiving Warfarin or Direct Oral Anticoagulants. Al-Rafidain Journal of Medical Sciences 2024;6(1):25-33.

Ziadé NR, Abi Karam G, Salloum N, et al. Transcultural adaptation and validation of the Arabic version of the compliance questionnaire for rheumatology. Acta Scientific Orthopaedics. 2020;3(10):26-34.

de Klerk E, Van der Heijde D, Van der Tempel H, et al. Development of a questionnaire to investigate patient compliance with antirheumatic drug therapy. The Journal of Rheumatology. 1999;26(12):2635-41.

Sarhan SA, Kamal DE, Hamed MS, et al. Validity and reliability of the Arabic version of the Self-Efficacy for Managing Chronic Disease scale in rheumatoid arthritis patients. Clinical Rheumatology. 2022;41(10):2967-75.

Lorig KR, Sobel DS, Ritter PL, et al. Effect of a self-management program on patients with chronic disease. Effective clinical practice. 2001;4(6):256-62.

Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI. A disease activity index for lupus patients. Arthritis & Rheumatism.Official Journal of the American College of Rheumatology. 1992;35(6):630-40.

Mahmoud H, Abdel Hamid Hawash M, Abd Elmaksoud M. Factors Affecting Adherence of Medication for Patients with Systemic Lupus Erythematous. Egyptian Journal of Health Care. 2022;13(3):1-17.

Refai RH, Hussein MF, Abdou MH, et al. A case–control study on health-related quality of life of systemic lupus erythematosus patients. Scientific Reports. 2024;14(1):1-8.

Barr AC, Clowse M, Maheswaranathan et al. Association of hurried communication and low patient self‐efficacy with persistent nonadherence to lupus medications. Arthritis care & research. 2023;75(1):69-75.

Chen Y, Chen B, Shen X, et al. A survey of systemic lupus erythematosus patients' attitudes toward influenza and pneumococcal vaccination in Southwest China. Frontiers in Public Health. 2022;10:1018899.

Jami Alahmadi S, Faezi ST, Mahmoudi M, et al. Medication Adherence in Patients with Systemic Lupus Erythematosus: A Descriptive Study. Rheumatology Research. 2020;5(1):7-12.

Du X, Chen H, Zhuang Y, et al. Medication adherence in Chinese patients with systemic lupus erythematosus. Journal of Clinical Rheumatology. 2020;26(3):94-8.

Mazur-Nicorici L, Sadovici-Bobeica V, Garabajiu M, et al. Therapeutic adherence in patients with systemic lupus erythematosus: a cross-sectional study. Romanian Journal of Internal Medicine. 2018;56(2):109-15.

Van't Land H, Verdurmen J, Ten Have M, et al. The association between arthritis and psychiatric disorders; results from a longitudinal population-based study. Journal of psychosomatic research. 2010;68(2):187-93.

Rodrigues L, Costa ML, Specian FC, et al. Quality of Life of Pregnant Women with Systemic Lupus Erythematosus. Brazilian Journal of Gynecology and Obstetrics. 2022;44:475-82.

Gergianaki I, Fanouriakis A, Adamichou C, et al. Is systemic lupus erythematosus different in urban versus rural living environment? Data from the Cretan Lupus Epidemiology and Surveillance Registry. Lupus. 2019;28(1):104-13.

Bogdanovic G, Stojanovich L, Djokovic A, et al. Physical activity program is helpful for improving quality of life in patients with systemic lupus erythematosus. The Tohoku journal of experimental medicine. 2015;237(3):193-9.

Butterly EW, Hanlon P, Shah AS, et al. Comorbidity and health-related quality of life in people with a chronic medical condition in randomised clinical trials: An individual participant data meta-analysis. PLOS Medicine. 2023;20(1):1-19.

Ibrahim MH, Ebrahim EA, Omar AS, et al. Correlates of Health-Related Quality of Life among Patients with Systemic Lupus Erythematosus. Trends in Nursing and Health Care Journal. 2023;7(2):189-208.

Hashemi S, Farahbakhsh S, Aghakhani Z, et al. Health-related quality of life and its related factors in patients with systemic lupus erythematosus in southwest Iran: a cross-sectional study. BMC psychology. 2023;11(1):259.

Gaballah NM, El-Najjar AR. Clinical characteristics and health related quality of life (HRQoL) in Egyptian patients with systemic lupus erythematosus. The Egyptian Rheumatologist. 2019;41(2):117-21.

Aldarwesh A, Almustanyir A, Alhayan D, et al. Self-Efficacy of Saudi Patients with Autoimmune Diseases in Managing Hydroxychloroquine-Induced Ocular Complications: A Cross-Sectional Survey. Healthcare. 2022;10(3):565.

Okediji A, Offiong U, Umoh O, et al. The influence of dwelling place and self efficacy on career decision-making. Global Journal of Humanities. 2008;7(1&2):19-25.

Hanrop S, Sriyuktasuth A, Pongthavornkamol K, et al. Factors influencing self-management behaviors in persons with lupus nephritis: A cross-sectional study. Belitung Nursing Journal. 2024;10(3):351-9.

Downloads

Published

2026-06-24